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ABSTRACT
Patients at risk for hereditary breast and ovarian cancer (HBOC) traditionally
participate in individual cancer genetic counseling sessions to be educated about cancer
genetics concepts, their personal cancer risks and genetic testing. With expanding
technology and increased public awareness of HBOC, referrals to cancer genetic
counseling services have grown. The current number of practicing genetic counselors
struggles to meet the demands of increased referrals, so new service delivery models need
to be explored. The purpose of this study is to assess the utility of group genetic
counseling for HBOC by evaluating the perspectives of patients that received group
genetic counseling versus perspectives of those that received individual genetic
counseling. We aimed to determine patient satisfaction and comfort level while also
assessing the time efficiency and patient receptiveness to group sessions. Sixty-eight
individuals with a new diagnosis of breast cancer participated, were randomly assigned to
group genetic counseling (n=30) or individual genetic counseling (n=38) and gave
perspectives on their genetic counseling session. Results demonstrate that each study
cohort reported high satisfaction with their genetic counseling session. Participants in the
group genetic counseling cohort were less likely to be overwhelmed by information given
in their appointments (p=0.01). Comfort levels were similar between the two study
groups and a majority of participants reported high comfort levels after their
appointment. A majority of participants in the individual genetic counseling stated that
they would not be willing to participate in group genetic counseling had they been given
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the choice and cited privacy and comfort as the main reasoning. Additionally, our study
found that group genetic counseling led to a significant savings in genetic counselor time
(p=0.0008). This study demonstrates that group genetic counseling shows promise by
reducing the genetic counselor time per patient, which allows for the ability to see more
patients, while providing similar satisfaction and benefits to patients as individual genetic
counseling models.
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CHAPTER 1
LITERATURE REVIEW
1.1 Overview of hereditary breast and ovarian cancer
In 2017, there were approximately 255,180 new cases of breast cancer in the
United States. Currently, breast cancer is the second leading cause of cancer death in
women, accounting for 40,610 deaths last year. While most of these cancers are sporadic,
5-10% of breast cancer has a hereditary component (ACS 2017). Because of this, The
National Comprehensive Cancer Network (NCCN) guidelines outline which patients
should be evaluated for Hereditary Breast and Ovarian Cancer (HBOC) syndromes. For
example, NCCN guidelines state that all patients with breast cancer at or under 50 years
old, those with triple-negative breast cancer at or under 60 years old, those with
metastatic HER2 negative breast cancer and those with breast cancer at any age meeting
specific family history criteria should receive genetic counseling for HBOC (NCCN
2019). Other professional societies, such as the American College of Obstetricians and
Gynecologists (ACOG), the American Cancer Society (ACS) and the Society of
Gynecologic Oncology (SGO), have also weighed in with criteria for patients that should
be referred for genetic counseling, including unaffected women with a family history
meeting specified criteria (ACOG 2015; SGO 2014; ACS 2017) . Detection of these
cancer predisposition syndromes can change patient management though the option of a
risk-reducing surgery, increased surveillance, and potential targeted therapy options. In
addition, identification of a hereditary cancer syndrome will impact at-risk family
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members. HBOC syndromes are caused by autosomal dominant inherited germline
pathogenic variants that result in an increased risk for cancers, such as breast and ovarian
cancer. BRCA1 and BRCA2 are high-risk genes that account for up to 50% of HBOC
cases. Starting in 1996, genetic testing for HBOC was focused on sequencing the BRCA1
and BRCA2 genes. However, as research has evolved, it has become clear that of those
with HBOC, only around 30% have been identified to have a BRCA1 and BRCA2
pathogenic variant through genetic testing (Okur et. al. 2017). With advancing research,
the genetics community has continued to research and learn more about other cancer
susceptibility genes that may confer risks to developing breast and ovarian cancer, such
as CHEK2, ATM, and PALB2 (Wang et. al., 2018). NCCN management guidelines for
individuals with pathogenic variants in these and several other genes are now available.
1.2 Evolution of genetic testing for cancer predispositions
With the advent of next-generation sequencing (NGS) technology, the clinical
approach to genetic testing in oncology has shifted. An increasing number of providers
are moving toward multi-gene panels, which allows clinicians to analyze for many
HBOC predisposition genes simultaneously (Crawford et. al. 2017). Additionally, studies
have shown that testing multiple genes simultaneously may be more efficient and cost
effective for patient diagnosis (Dancey et. al. 2012). There has been a rapid growth in the
number of multi-gene panel genetic tests available in recent years. From March 2014 to
August 2017, 14,000 new genetic tests became available, with about two to three panel
tests entering the market every day (Phillips et. al. 2018). This evolution toward panel
testing has resulted in the improved identification of pathogenic variant carriers but has
also challenged the understanding of the expression of these gene pathogenic variants.
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Through advances in genetic testing technology, researchers and clinicians have been
able to identify and consequently test for many more genes that confer a high lifetime
risk of specific cancers (Okur et. al. 2017).
Increased knowledge of genetic predisposition genes has uncovered that some
groups of patients who have undergone BRCA1 and BRCA2 testing in the past with
negative results may benefit from being tested again with more comprehensive panels.
Our current technologies have increased the detection rate of deletions and duplications
in BRCA1 and BRCA2, which could uncover pathogenic variants in these genes that were
previously not found. Also, patients with previously negative results on previous BRCA1
and BRCA2 tests may have one or more pathogenic variants in other HBOC genes. In a
recent study, it was found that 9% of a retested cohort had a pathogenic variant in a gene
that predisposes a higher risk of breast cancer (Crawford et. al. 2017). Of the identifiable
mutations in the retested cohort, 8% were in genes other than BRCA1 and BRCA2.
With more individuals being tested for cancer predisposition gene pathogenic
variants, there has been an increased public awareness of cancer genetics and risk. The
so-called “Angelina Jolie effect” has been described in the literature (Guo et. al. 2017). In
May 2013, actress Angelina Jolie wrote an op-ed, published in the New York Times,
sharing her experience about undergoing genetic testing and discovering she had a
pathogenic variant in the BRCA1 gene. She openly shared her decision making process
that led to a risk-reducing double mastectomy and oophorectomy (Jolie 2013). News
media outlets publicized her story and experience across the world. In studies conducted
in the UK, researchers found that referrals to genetic counseling services increased nearly
2.5 fold in the months following public dissemination of Angelina Jolie’s genetic testing
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experience. In a retrospective United States study looking at the number of BRCA1 and
BRCA2 tests ordered following Jolie’s article, there was an 80% increase in the number
of BRCA1 and BRCA2 tests from April 2013 to June 2013 (Guo et. al. 2017). Referral
and testing rates have continued to stay at an increased rate and demand for BRCA1 and
BRCA2 testing specifically has increased among patients and providers. This “Angelina
Jolie effect” has been global in its reach and appears to have impacted the increase in
referrals to cancer genetics and genetic counseling (Evans et. al. 2014; Guo et. al. 2017).
Precision medicine efforts have turned toward the use of targeted therapies for
cancer in both individuals who have somatic pathogenic variants in their tumor and those
with germline pathogenic variants. These therapies have offered dramatic improvements
in the treatment of cancer. Beginning in 2010, oncologists began researching a class of
drugs called PARP inhibitors to treat ovarian cancers in individuals with a germline
BRCA1 or BRCA2 pathogenic variant. Treatment of BRCA1 and BRCA2 positive patients
with PARP inhibitors has been associated with higher survival rates than those without
BRCA1 or BRCA2 pathogenic variants that are treated with PARP inhibitors. Drugs have
also been approved for those with metastatic HER2-negative breast cancer who carry a
germline pathogenic variant in BRCA1 or BRCA2 (Konecny et. al 2016).
Together, the advent of new technologies, increased public awareness of BRCA1
and BRCA2 and personalized medicine efforts have resulted in an increase in referrals for
genetic counseling for hereditary cancer risk assessment and a need for more genetic
counselors (Buchanan et. al. 2016). The availability of genetic counselors is one of the
rate limiting factors for patient access to genetic counseling services (Hoskovec et. al.
2018). With the current number of practicing genetic counselors, there are struggles to
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meet the demands for genetic counseling referrals. It has been predicted that with the
increased demand for genetic counseling, the supply of genetic counselors will not meet
needs until 2024-2030 (Hoskovec et. al. 2018). This underscores the need to evaluate the
effectiveness of current delivery service models and consider other service delivery
models (SDM) that can be implemented into the cancer genetics clinic to increase access.
1.3 Genetic counseling service delivery models
1.3.1 Individual genetic counseling
The usual standard of care for cancer genetic counseling has followed the
traditional service delivery model which involves one-on-one in-person initial sessions
with follow up and results disclosure occurring by telephone or other means (Cohen et.
al. 2013). According to the 2018 Professional Status Survey report from the National
Society of Genetic Counselors (NSGC), 96% of genetic counseling is performed using
this method (NSGC 2018). The essential elements of cancer genetic counseling sessions
include: intake of personal and family medical history, cancer risk assessment and
education, pretest counseling, informed consent for genetic tests and psychosocial
assessment (Riley et. al. 2012). The purpose of cancer genetic counseling is to identify
and counsel individuals at increased risk of developing cancer and distinguish between
those that are at high or moderate risk and those at average risk. It utilizes a combination
of pedigree analysis and genetic testing to identify hereditary cancer syndromes and
explain specific cancer risks for individual patients. This information is then used to
develop a management plan for cancer screening, prevention, and risk-reduction (Riley
et. al 2012). These elements assist in helping patients understand complex genetic and
risk information to make informed decisions about their healthcare while also addressing
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psychosocial concerns that may arise. With the introduction of multi-gene panel testing,
genetic counselors have had to shift the way they approach education about testing
options for hereditary cancer. In the past, genetic counseling educational efforts focused
on specific genes, like BRCA1 and BRCA2, but current education has become broader
when discussing multi-gene panels. It is difficult to educate patients about all the possible
manifestations in the many genes that are being tested, so cancer genetic counselors have
adopted a more general education focus regarding cancer genes and possible risk
scenarios (Okur et. al. 2017).
Traditional individual sessions allow for genetic counselors to tailor information
for the patient’s specific risk and psychological needs (Rothwell et. al. 2012). Research
has shown that long-term outcomes for patients participating in traditional HBOC cancer
genetic counseling sessions include decrease in anxiety, improved accuracy of perceived
risk, and overall satisfaction (Meiser et. al. 2001). However, this service delivery model
has proven to be appreciably time intensive with most sessions requiring an average time
of 46-60 minutes, and most genetic counselors reporting that they see 8-9 patients per
week (Wham et. al 2010). Finally, patients typically have to wait an average of 1-3 weeks
to get an individual, in-person cancer genetic counseling session upon referral (NSGC
2018). Advances in precision medicine allow surgeons and patients to make more
informed surgery decisions based on germline genetic testing results, so reduced wait
times for appointments are paramount. To keep up with genetic expertise demands and
technological advances, effective service delivery models for genetic counseling need to
be explored to find ways of optimizing patient consultation, education, and testing
(Cohen et. al. 2016).
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1.3.2 Alternative genetic counseling service delivery models
Many SDMs have been investigated in the field of genetic counseling. While use
is relatively infrequent and typically not the sole method practiced, telephone genetic
counseling, telegenetics, and group genetic counseling have shown promise in the field of
genetic counseling (Buchanan et. al. 2016). Initial expected advantages of these
alternative methods are convenience, decreased travel time, improved access to care, and
reduced wait times. Disadvantages include logistical issues with billing and
reimbursement, equipment set up, making arrangements for genetic testing, and the
inability to see the patient. However, genetic counselors currently using SDMs reported
that the convenience to the patient and genetic counselor outweighs the disadvantages to
alternative SDMs used (Cohen et. al. 2016).
1.3.3 Telephone genetic counseling
Telephone genetic counseling is the second most frequent SDM being used with
59% of genetic counselors reporting that they utilize this model at least some of the time
(NSGC 2018). Of this group, cancer genetic counseling was the most reported specialty
practicing this SDM. A majority of genetic counselors who reported using telephone
counseling also reported using another service delivery model in conjunction. Patients
accessing telephone genetic counseling tend to live farther distances from clinics offering
genetic counseling, with a majority reporting that they live over four hours away (Cohen
et. al. 2013). In a randomized trial comparing telephone genetic counseling and in-person
genetic counseling for BRCA1 and BRCA2, the authors found similar high satisfaction
with genetic counseling in each group (Peshkin et. al. 2016). Additionally, the telephone
genetic counseling group found that the genetic counseling session was more convenient
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for them compared to driving to the clinic. During telephone sessions, some of the
patients experienced technological difficulties with the telephone. Surprisingly, this was
not found to have an impact on satisfaction. However, those who received telephone
genetic counseling perceived lower levels of support and emotional recognition then
those who had in-person genetic counseling. They also were more likely to report that
they had difficulty maintaining attention during their session. In similar studies, no
difference in patients’ knowledge, distress, decisional conflict, and cancer worry were
seen between the telephone counseling and in-person genetic counseling groups (Platten
et. al. 2012; Schwartz et. al. 2014). Cost savings have also been seen for patients and
institutions using telephone genetic counseling over in-person cancer genetic counseling
(Schwartz et. al. 2012). Overall, convenience for provider and patient, decreased cost,
and similar satisfaction ratings are justifications for telephone genetic counseling, but
challenges still persist with technological complications, deficits in perceived
psychosocial support from genetic counselors, and difficulties in patient attentiveness
with telephone genetic counseling when compared to an in-person SDM.
1.3.4 Telegenetics
Telegenetics, or providing genetic counseling via live videoconferencing, has
also been studied and appears promising as an effective SDM in genetic counseling
clinics. Around 18% of genetic counselors report using this model at times in their
practice, but it is rarely the sole SDM used by a genetic counselor (NSGC 2018).
Typically, this SDM consists of an urban genetics clinic providing genetic counseling to a
patient who has come to a different, often rural, healthcare facility closer to their home to
have genetic counseling. Some disadvantages of this method from a provider point of
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view include obtaining support staff at the remote side and having a physical space at
both the host and remote location (Cohen et. al. 2016). However, this model has been
shown to reduce costs and patients receiving this method of genetic counseling have
reported similar satisfaction as those having in-person genetic counseling sessions
(Buchanan et. al. 2015). In a study of cancer telegenetics use in a geographically remote
setting of Maine, it was found that this model may also help increase access to cancer
genetic counseling services in underserved areas (McDonald et. al. 2014). Unlike
telephone genetic counseling, telegenetics has been shown to facilitate psychosocial
assessment as well as in-person cancer genetic counseling (Zilliacus et. al. 2011).
However, in a randomized trial of telegenetics versus in-person cancer genetic
counseling, in-person genetic counseling patients were more likely to attend their
appointments. They found that 32% of their study population reported that they would
have preferred in-person genetic counseling (Buchanan et al. 2015). Similar to telephone
genetic counseling, technology problems were a disadvantage to this SDM. In this study,
15% of the sessions experienced technical problems, and consequently, 7% had to be
rescheduled (Buchanan et al. 2015). In summary, telegenetics may provide similar
psychosocial and satisfaction benefits as in-person genetic counseling while reducing
costs, but poor attendance and technological problems are disadvantages for this SDM.
1.3.5 Group genetic counseling
An encouraging SDM that may not have the disadvantages experienced in
telephone genetic counseling or telegenetics is group genetic counseling. This method is
currently the least used alternative, with only 7% of genetic counselors reporting that they
utilize this SDM at least some of the time (NSGC 2018). Most of the genetic counselors
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using group methods report utilizing this SDM less than 10% of the time in their practice
and instead rely on other SDMs for a majority of their practice. Typically, in group
genetic counseling, patients with similar or the same indications will have pretest genetic
counseling together. This is sometimes followed by shorter individual discussions to
address personal issues or specific family history (Buchanan et. al. 2016).
Many studies have corroborated that group genetic counseling has similar
satisfaction ratings and knowledge scores compared to individual in-person genetic
counseling (Benusiglio et. al. 2017; Buchanan et. al.2016; Cloutier et. al. 2017; Listol et.
al. 2017; Otten et. al. 2015; Ridge et. al. 2009). In a study of group genetic counseling in
HBOC patients, satisfaction was similar to those who had individual genetic counseling
sessions and knowledge scores significantly increased between pre- and postassessments in both group and individual genetic counseling sessions (Calzone et. al.
2005). Additionally, group genetic counseling has been found to have a similar
attendance rate to traditional methods (Benusiglio et. al. 2017). This provides preliminary
evidence that group genetic counseling does not inhibit the patient’s ability to learn new
information and may have better attendance then telegenetics.
Group genetic counseling also appears to confer similar psychosocial benefits as
individual in-person genetic counseling. In a study looking at group genetic counseling in
the prenatal setting for women with positive integrated prenatal screening or maternal
serum screening for Down syndrome, the authors found that outcomes for decisional
conflict were similar to that of patients who participated in traditional individual genetic
counseling. However, they found that anxiety decreased more significantly in individual
genetic counseling compared to group settings. The authors concluded that this may be
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because individuals seen in the group setting did not have the opportunity to meet with a
genetic counselors one-on-one in this particular study (Cloutier et. al. 2017). This could
indicate that one-on-one genetic counseling following the group session is important for
reducing patient anxiety.
The Impact of Event Scales (IES) measures intrusive thoughts, avoidance, denial,
and blocking of thoughts related to a specific life event or stressor. In one study looking
at group versus individual genetic counseling for those at high risk for harboring a BRCA
pathogenic variant, they found that IES were similar in group sessions when compared to
in-person genetic counseling (Calzone et. al. 2005). Another similar study found that
depressive symptoms and anxiety were similarly decreased in group genetic counseling
when compared to individual genetic counseling (Listol et. al. 2017; Otten et. al. 2015).
Perceived personal control has also been found to be similar between individual and
group genetic counseling methods (Rothwell et. al. 2012). This provides preliminary
evidence that group genetic counseling does not increase patient distress and is meeting
psychosocial needs similarly to individual genetic counseling.
Shared experiences between patients has been shown to be a unique benefit of
group genetic counseling when individuals have the opportunity to discuss experiences
and concerns within the group. In a study of group genetic counseling, researchers found
that these opportunities helped women to feel supported in group genetic counseling
sessions and promoted normalization (Ridge et. al. 2009). This may be a promising
advantage to group genetic counseling compared to individual methods because an
important part of the genetic counseling process is providing patient support.
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Group genetic counseling has shown promise for increasing efficiency by
decreasing per-patient time for genetics providers. Most genetic counselors report
spending less than 30 minutes on individual components of the session, compared to 4660 minutes for traditional genetic counseling methods (Buchanan et. al 2016; Cohen et. al
2013). Clinicians have reported being able to see more patients in a shorter amount of
time which may help to increase access to genetics services. In a study assessing group
genetic counseling in an underserved population in Texas, researchers found that group
genetic counseling allowed increased access to cancer genetic services by allowing
limited providers to spend less time per patient and consequently see more patients and
reduce wait times (Woodson et. al. 2015). A majority of genetic counselors utilizing this
SDM reported that they do not bill for their service; however, when genetic counselors
did bill, they most commonly used the 96040 GC code, followed by consultation codes
99241-99245 or 99251-99255 and evaluation and management codes 99201-99205 or
99211-99215 (Cohen et. al. 2013).
While preliminary research has demonstrated some potential benefits of group
genetic counseling, there are potential challenges with this SDM. In a study of group
genetic counseling for HBOC, they found that group interactions were associated with
tension or lack of comfort, especially when some individuals in the group met criteria for
testing while others did not. Genetic counselors have found difficulty in accommodating
specific individual needs, diffusing group conflict, and maintaining confidentiality while
in group sessions (Ridge et. al. 2009). These findings suggest that group genetic
counseling for same indications instead of similar indications may be more favorable in
the cancer setting to help reduce undesirable group interactions. A single study found that
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a group setting was associated with fewer individuals undergoing genetic testing
compared to those in an individual setting (Rothwell et. al. 2012). This may be attributed
to group influences on decision making but this discrepancy in test uptake has not been
evaluated in other studies. Finally, questions remain about whether group genetic
counseling would be widely accepted by cancer genetic counseling patients and
providers. One study found that a high rate of patients initially declined group genetic
counseling and reported a concern about privacy and decision making in a group setting
(Ridge et. al. 2009).
1.4 Rationale
Although there are several publications analyzing group genetic counseling, many
studies have been non-randomized and allow patients to choose their preferred method of
genetic counseling (Buchananan et al 2016; Listol et al 2017; Otten et al 2015; Ridge et
al 2009; Rothwell et. al 2012; Woodson et al 2015). Inherent bias may play into the
patient responses within these studies. More studies need to address patient satisfaction
and opinions in a randomized fashion to better understand patient’s perceptions and
acceptability of group genetic counseling. Additionally, most studies were conducted and
evaluated based on genetic counselors disseminating education on BRCA1 and BRCA2
testing only. As panel testing continues to be prevalent in cancer genetic counseling,
group genetic counseling needs to be reassessed as an acceptable SDM.
1.5 Purpose
As cancer predisposition genetic testing referrals increase, streamlined approaches
to genetic counseling and education are needed to allow for better access to genetic
services. Service delivery models such as group genetic counseling may help meet the
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demand while maintaining quality of care. The purpose of this study was to assess the
utility of group genetic counseling for HBOC by evaluating patient perspectives of group
genetic counseling versus patient perspectives of individual genetic counseling. The aims
of the study are as follows:
1. Determine patient satisfaction and comfort level with group genetic counseling.
This will be measured by questionnaires that assess cancer genetic counseling
satisfaction, patient comfort and distress.
a. Hypothesis: Those participating in group genetic counseling will be as
satisfied and comfortable as those participating in individual genetic
counseling.
2. Evaluate the time efficiency of group genetic counseling compared to individual
genetic counseling which can impact access to genetic counseling services. This
will be measured by comparing the amount of genetic counselor time spent per
patient in each service delivery model.
a. Hypothesis: Group genetic counseling will reduce provider time per
patient compared to individual genetic counseling.
3. Determine if patients are receptive to participating in group genetic counseling
sessions for HBOC. This will be assessed by investigating if participants
receiving individual genetic counseling would be willing to participate in group
genetic counseling sessions in the future.
a. Hypothesis: Participants receiving individual genetic counseling sessions
will be hesitant to participate in group genetic counseling sessions.
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Overall, this study aims to provide insight into a service delivery model that may improve
the efficiency of hereditary breast and ovarian cancer genetic counseling while
maintaining the current high levels of patient satisfaction and comfort.
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CHAPTER 2

IMPACT OF SERVICE DELIVERY MODEL ON PATIENT PERCEPTIONS AND
UTILITY OF GENETIC COUNSELING FOR HEREDITARY BREAST AND
OVARIAN CANCER: AN EXPLORATION OF GROUP GENETIC COUNSELING
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2.1 Abstract
Patients at risk for hereditary breast and ovarian cancer (HBOC) traditionally
participate in individual cancer genetic counseling sessions to be educated about cancer
genetics concepts, their personal cancer risks and genetic testing. With expanding
technology and increased public awareness of HBOC, referrals to cancer genetic
counseling services have grown. The current number of practicing genetic counselors
struggles to meet the demands of increased referrals, so new service delivery models need
to be explored. The purpose of this study is to assess the utility of group genetic
counseling for HBOC by evaluating the perspectives of patients that received group
genetic counseling versus perspectives of those that received individual genetic
counseling. We aimed to determine patient satisfaction and comfort level while also
assessing the time efficiency and patient receptiveness to group sessions. Sixty-eight
individuals with a new diagnosis of breast cancer participated, were randomly assigned to
group genetic counseling (n=30) or individual genetic counseling (n=38) and gave
perspectives on their genetic counseling session. Results demonstrate that each study
cohort reported high satisfaction with their genetic counseling session. Participants in the
group genetic counseling cohort were less likely to be overwhelmed by information given
in their appointments (p=0.01). Comfort levels were similar between the two study
groups and a majority of participants reported high comfort levels after their
appointment. A majority of participants in the individual genetic counseling stated that
they would not be willing to participate in group genetic counseling had they been given
the choice and cited privacy and comfortability as the main reasoning. Additionally, our
study found that group genetic counseling led to a significant savings in genetic
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counselor time (p=0.0008). This study demonstrates that group genetic counseling shows
promise by reducing the genetic counselor time per patient, which allows for the ability
to see more patients, while providing similar satisfaction and benefits to patients as
individual genetic counseling models.
2.2 Introduction
In 2017, there were approximately 255,180 new cases of breast cancer in the
United States. While most of these cancers are sporadic, 5-10% of breast cancer has a
hereditary component (ACS 2017). The National Comprehensive Cancer Network
(NCCN) guidelines outline which patients should be evaluated for Hereditary Breast and
Ovarian Cancer (HBOC) syndromes. Detection of these cancer predisposition syndromes
can change patient management through the option of a risk-reducing surgery, increased
surveillance, and possible targeted therapy options. In addition, identification of a
hereditary cancer syndrome will impact at-risk family members. The most common genes
implicated in HBOC are BRCA1 and BRCA2. In the past, genetic testing for HBOC has
focused on sequencing of BRCA1 and BRCA2 genes, however, as research has evolved, it
has become clear that there are many more genes that cause HBOC (Okur et. al. 2017).
The genetics community has continued to research and learn more about these other
cancer susceptibility genes, such as CHEK2, ATM and PALB2 (Wang et. al., 2018) and
NCCN management guidelines for individuals with these pathogenic variants are now
available.
With the advent of next-generation sequencing (NGS) technology, the clinical
approach to genetic testing in oncology has shifted. An increasing number of providers
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are moving toward utilizing multi-gene panels (Crawford et. al. 2017), which allows
clinicians to analyze for many HBOC predisposition genes simultaneously. This
evolution toward panel testing has resulted in the improved identification of pathogenic
variant carriers, as well as challenged the understanding of the expression of these gene
pathogenic variants. NGS testing methodology has also improved the detection rate of
pathogenic variants in BRCA1 and BRCA2.
With more individuals being tested for cancer predisposition genes, there has been
an increased public awareness of cancer genetics and risk. In May 2013, actress Angelina
Jolie wrote an op-ed sharing her experience undergoing genetic testing and finding she
had a pathogenic variant in the BRCA1 gene. She openly shared her decision-making
process that led to a risk-reducing double mastectomy and oophorectomy (Jolie 2013).
Studies have found that genetic counseling referrals and the number of BRCA1 and
BRCA2 tests ordered have increased since this widely publicized story (Evans et. al 2014;
Guo et. al. 2017). As demand for services has evolved, precision medicine efforts have
also turned toward the use of targeted therapies both for individuals who have tumor
pathogenic variants and those with germline pathogenic variants. These therapies have
offered dramatic therapeutic improvements in the treatment of cancer. For example,
oncologists now use a class of drugs called PARP inhibitors to treat ovarian cancers and
metastatic HER2-negative breast cancers in individuals with BRCA1 or BRCA2
pathogenic variants (Konecny et al. 2016; Dancey et al. 2012).
Together, the advent of new technologies, increased public awareness of BRCA1
and BRCA2 and personalized medicine efforts have resulted in an increase in referrals for
genetic counseling for hereditary cancer risk assessment and a need for more genetic
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counselors (Buchanan et. al. 2016). With the current number of practicing genetic
counselors, there are struggles to meet the demands for genetic counseling referrals. It
has been predicted that with the increased demand for genetic counseling, the supply of
genetic counselors will not meet needs until 2024-2030 (Hoskovec et. al. 2018). This
underscores the need to evaluate the effectiveness of current delivery service models and
consider other service delivery models (SDM) that can be implemented into the cancer
genetics clinic in order to increase access.
The current standard of care for cancer genetic counseling has followed the
traditional service delivery model which involves one-on-one in-person initial sessions
with follow up and results disclosure occurring by telephone or other means (Cohen et.
al. 2013). The essential elements of cancer genetic counseling sessions include: intake of
personal and family medical history, cancer risk assessment and education, pretest
counseling, informed consent for genetic tests and psychosocial assessment (Riley et. al.
2012). It utilizes a combination of pedigree analysis and genetic testing to identify
hereditary cancer syndromes and explain specific cancer risks for individual patients.
This information is then used to develop a management plan for cancer screening,
prevention and risk-reduction (Riley et. al 2012). These elements assist in helping
patients understand complex genetic and risk information to make informed decisions
about their healthcare while also addressing psychosocial concerns that may arise.
However, since the increase in panel testing, genetic counselors have had to shift the way
they approach education about cancer and testing options. In the past, genetic counseling
has focused on specific genes, like BRCA1 and BRCA2, but current education has become
broader when discussing multi-gene panels.
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Research has shown that long-term outcomes for patients participating in
individual HBOC cancer genetic counseling include decrease in anxiety, improvements
in perceived risk, and overall satisfaction (Meiser et. al. 2001). However, this service
delivery model has proven to be appreciably time intensive and results in increased
patient wait times. To keep up with genetic expertise demands and technological
advances, effective alternative genetic service delivery models need to be explored to
find ways of optimizing patient consultation, education and testing (Cohen et. al. 2016).
An encouraging new SDM is group genetic counseling. Typically, in group
genetic counseling, patients with similar or the same indications will have pretest genetic
counseling together. This is sometimes followed by shorter individual discussions to
address personal issues or specific family history (Buchanan et. al. 2016).
Many studies have corroborated that group genetic counseling has similar
satisfaction ratings and knowledge scores compared to individual genetic counseling.
Group genetic counseling has also been found to have similar attendance rates compared
to traditional methods (Benusiglio et. al. 2017). This provides preliminary evidence that
group genetic counseling does not inhibit the patient’s ability to learn new information
and may have better attendance then some of the other alternative SDMs utilized (e.g
telephone genetic counseling and telegenetics).
Group genetic counseling appears to confer similar psychosocial benefits when
compared to individual genetic counseling. Several studies have shown that this SDM
does not increase patient distress or decrease patient comfort (Calzone et. al. 2005; Listol
et. al. 2017; Otten at. al. 2015). Shared experiences between patients has been shown to
be a benefit of group genetic counseling when individuals have the opportunity to discuss
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experiences and concerns with a group. This may be a promising advantage to group
genetic counseling compared to individual methods because an important part of the
genetic counseling process is providing patient support.
Additionally, this SDM has also shown promise for increasing efficiency by
decreasing per-patient time for genetics providers. In many studies, clinicians have
reported being able to see more patients in a shorter amount of time, helping increase
access to cancer genetic services in their clinics.
While preliminary research has demonstrated some potential benefits of group
counseling, there are potential challenges with this SDM. Group interactions may cause
tension, especially when some individuals in the group met criteria for testing while
others did not. Genetic counselors have found difficulty in accommodating specific
individual needs, diffusing group conflict, and maintaining confidentiality while in group
sessions (Ridge et. al. 2009). These findings may indicate that group genetic counseling
for same indications instead of similar indications may be more favorable in the cancer
setting to help reduce undesirable group interactions. Some studies have also found
decreased test uptake with group genetic counseling sessions. Finally, questions remain
about whether group counseling would be widely accepted by cancer genetic counseling
patients.
Most studies of group genetic counseling have been non-randomized and allow
for patients to choose their preferred method of genetic counseling. Inherent bias may
play into the patient responses within these studies. Our study aims to address patient
satisfaction and opinions in a randomized fashion to better understand patient’s
perceptions and acceptability of group genetic counseling. Also, a majority of studies
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were conducted and evaluated based on genetic counselors disseminating education on
BRCA1 and BRCA2 testing only. As panel testing continues to be prevalent in cancer
genetic counseling, group genetic counseling needs to be reassessed as an acceptable
SDM. Our methods include evaluating group genetic counseling with the inclusion of
panel genetic testing education.
The purpose of this study is to determine patient satisfaction and comfort level
with group genetic counseling. We aim to evaluate the time efficiency of group genetic
counseling compared to individual genetic counseling, as well as test uptake between the
two groups. Additionally, we want to assess if patients would be willing to participate in
group genetic counseling if given the option. We predict that group genetic counseling
will have high satisfaction levels and will improve efficiency. We also believe that
patients will be willing to participate in group genetic counseling if given the choice.
2.3 Materials and Methods
2.3.1 Participants
Eligible participants were newly diagnosed breast cancer patients who met NCCN criteria
for HBOC genetic risk evaluation and were referred to Palmetto Health USC Medical
Group for hereditary cancer genetic counseling. Only English-speaking participants were
included in the study due to limited resources available for interpretation from English to
other languages. Participants were enrolled from August 2018 to February 2019.
2.3.2 Procedure
Palmetto Health USC Medical Group Cancer Genetic Counseling clinic implemented
group genetic counseling sessions into their practice beginning in August 2018 to find
new methods for reducing provider time per patient. Patients referred for the indication of
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newly diagnosed breast cancer were scheduled in a group genetic counseling session that
occurred once a week. A maximum of four patients were scheduled for one group genetic
counseling session. The remaining referrals in that week were assigned to individual
genetic counseling sessions. If there were not at least two patient referrals during any
given week, a group genetic counseling session was not held. If time permitted, family
medical history was taken over the phone prior to the session by a USC genetic counselor
or genetic counseling assistant. Those who did not have their family history taken over
the phone prior to their session had family history intake during their sessions. For the
group genetic counseling cohort, this meant that the family history was taken during the
individual portion following the group genetic counseling session. For participants with
family history taken over the phone prior to their session, the provider assessed if the
patient’s family history was indicative of cancer a non-HBOC syndrome, or if there was a
known pathogenic variant carriers in the family. If either of these situations were
encountered, the patient was re-assigned to an individual cancer genetic counseling to
maintain group uniformity.
For the group genetic counseling sessions, genetics education was given by one of
the three board-certified cancer genetic counselors at USC. This education piece operates
much like a typical individual genetic counseling session where hereditary cancer genes,
inheritance, management guidelines, test options, and possible test results are described.
The genetic counselor used similar visual aids to those used in individual genetic
counseling sessions to explain concepts to the group, and patients were given the
opportunity to ask questions about the material throughout. Following the group session,
each patient was seen individually by one of the three USC cancer genetic counselors to
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either take the pedigree (if needed) or review any pertinent family history, provide
personalized risk assessment, and address any personal questions and psychosocial
concerns in private. During this part, decisions were made about genetic testing, and the
consent form was signed. A physician then met briefly with the patient as part of the
billing and check out process, which is also standard in our individual genetic counseling
sessions.
Following a completed genetic counseling session, whether provided in a group
setting or individual setting, patients were invited to participate in the study. Interested
participants were asked to read the recruitment letter (Appendix A). Those who agreed to
participate completed the post-genetic counseling questionnaire pertinent to the method
of genetic counseling they received – either group or individual genetic counseling.
Participants that completed the survey could enter their name into a raffle for a gift card.
Personal information was maintained separate from the questionnaire.
The genetic counselor conducting the session recorded the number of minutes
spent in each session, including the one-on-one portion and the group portion of the
group genetic counseling sessions. We calculated overall counselor time spent per patient
for both the individual and group genetic counseling cohorts. Due to changes in the preappointment process during the study period, we separated the participants who had their
family history taken over the phone before the session by a genetic counseling assistant
and the participants who had their family history taken in person during their sessions.
Our analysis primarily focused on data from participants who had their family history
taken during the session. Overall time was calculated by taking the sum of time spent
with patients and dividing it by the number of patients seen. Counselor time per patient
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for also calculated for those who had their family history taken over the phone prior to
their genetic counseling session.
2.3.3 Instrument
One questionnaire was developed for each type of session - individual and group genetic
counseling (Appendix B and Appendix C). We measured patient satisfaction in both
questionnaires using an adaption of a widely validated cancer genetic counseling
satisfaction measure (DeMarco et. al. 2004). This measure included a Likert-scale from
one (strongly disagree) to five (strongly agree). The original measure published by
DeMarco et. al. has six items, however we added a seventh and eighth item: “I felt that
the information was overwhelming” and “I feel like I understood the information
presented during my appointment”. This addition was used to assess patient perceptions
of feeling overwhelmed and their assessment of their own comprehension of the
information in their counseling session. The scale had a low level of internal consistency,
as determined by a Cronbach’s alpha of 0.508. As a result, each item on the measure was
analyzed individually instead of as a combined satisfaction score. Participants were also
asked in both arms to rank their overall satisfaction on a scale of one (least satisfied) to
five (most satisfied). Both questionnaires concluded with questions to gather
demographic information (e.g. age, race, education level) and an open response question
to leave any comments, suggestions, or concerns.
Both study cohorts’ questionnaire had a comfort and anxiety measure that shared
4 items. Each item used a Likert-scale from one (strongly disagree) to five (strongly
agree). The measure had a low level of internal consistency, as determined by a
Cronbach’s alpha of 0.138. As a result, each item on the measure was analyzed
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individually instead of as a combined score. The group genetic counseling questionnaire
also had an additional 5-item measure assessing comfort and necessity for the individual
portion of their genetic counseling experience using the same Likert-scale. Spaces for
open response about experiences in both the group and individual portion of the group
genetic counseling session was included after each measure. The individual genetic
counseling questionnaire also had a unique item that assessed if patients would be willing
to receive their genetic counseling in a group setting using a scale from 1 (not willing) to
5 (most willing). An open response question assessing reasoning for this response was
listed below to gain more insight into patient opinions and ideas.
2.3.4 Statistical analysis
Both quantitative and qualitative data were captured in survey responses. Reliability
analysis using Cronbach’s alpha was conducted on the satisfaction and
comfortability/anxiety measures. Descriptive statistics were conducted for all variables
within each study group. Chi-squared tests were used to determine significant
demographic differences between each group. In situations where only two variables
existed, Fisher’s exact test was used to determine significant differences. Independent
sample t-tests were conducted to analyze the questionnaire items and compare the two
study group means. ANOVA analysis was then conducted for statistically significant
items identified from our independent sample t-test to determine effect size. ANOVA
analysis was also used to determine differences in responses to items based on
demographics of the participants. SPSS software was used for data analysis and a p-value
of 0.05 was used to indicate statistical significance. Due to lack of responses in the open-
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ended questions, the principal investigator and co-authors descriptively summarized the
qualitative data instead of coding the data.
2.4 Results
2.4.1 Demographic information
A total of 68 individuals participated in our study; 38 individuals who had
individual genetic counseling (56%) and 30 who had group genetic counseling (44%).
Demographic characteristics of the participants are summarized in Table 2.1. The sample
population consisted of mostly Caucasian (60.3%; n = 41), Non-Hispanic (85.3%, n=58)
individuals. All participants were female with a mean age of 54 years old. A majority
reported having at least a bachelor’s degree (51.5%, n=35). Of the 50 individuals (74%)
whom responded to the demographic question regarding income, most reported an
income of $25,000-$50,000 (25%, n=17). A majority of participants reported having
private or employer based health insurance (61.8%, n=42), being married (61.8%, n=42),
and having a family history of cancer (80.9%, n=55). Most individuals did not bring
anyone with them to their appointment (55.8%, n=40); however, of the 28 that did, it was
most often a significant other (46.4%, n=13). Demographic characteristics of the
participants in each study group (group and individual genetic counseling) is also
summarized in Table 2.1. No statistically significant difference in demographics was
appreciated between the individuals participating in group versus individual genetic
counseling. For the group genetic counseling cohort, the average group size was 2.5
patients (range 2-4 patients).
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2.4.2 Satisfaction
Participants in both study groups were asked to complete a measure that used an
eight-item Likert-scale measure (1 = strongly disagree; 5 = strongly agree) to assess
satisfaction, overwhelming feelings and perceived clarity of the information covered in
their session. A summary of the means for each item per study group is listed in Figure
2.1. For the individual genetic counseling study group, the participants most strongly
agreed with the items “The genetic counseling (GC) appointment was valuable to me”
and “My genetic counselor helped me to identify what I needed to know to make
decisions about what would happen” (M=4.89, 4.87 respectively). For the group genetic
counseling study group, the participants most strongly agreed with the items “The genetic
counseling appointment was the right length of time I needed”, “The GC appointment
was valuable to me”, and “I feel like I understood the information presented during my
appointment” (M=4.97, 4.93 and 4.93 respectively) Overall, both study groups ranked
most items as 4 or greater which correlates with “agree somewhat” or “strongly agree”;
however, the group genetic counseling study group reported slightly higher ratings on
most items compared to those participating in individual genetic counseling sessions
although there was no statistically significant difference. For both study groups, most
participants disagreed with the item “I felt that the information was overwhelming” with
the individual genetic counseling group cohort rating an average of 2.74 and the group
genetic counseling cohort rating an average of 1.77. Independent samples t-tests and
ANOVA was run to determine if there were significant differences in the responses
between the two study cohorts and the effect size. This showed statistical significance
that those in group genetic counseling reported feeling less overwhelmed from the
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information given compared to those in individual genetic counseling sessions (p-value =
0.01, η² = 0.31).
Those in group genetic counseling rated the item “The GC appointment was the
right length of time I needed” higher than those participating in individual genetic
counseling with analysis approaching statistical significance (p-value = 0.057; η²= 0.23).
Overall, the remaining items on this measure were comparable between the two study
groups and no significant differences were appreciated (Table 2.1) as both groups
reported high levels of satisfaction and value in their genetic counseling experience and
low levels of feeling overwhelmed. ANOVA analysis was used to determine if there were
differences in overall satisfaction and feelings of being overwhelmed based on
demographic information provided. Analysis demonstrated that those who reported being
a widow were less satisfied overall with their genetic counseling appointments (p-value =
0.04; η²= 0.44) and those who were single or divorced were more overwhelmed by the
information given during their genetic counseling sessions (p-value = 0.02; η²= 0.47) in
both the group and individual genetic counseling cohorts. No other differences in
satisfaction and feelings of being overwhelmed were significantly associated with
demographic variables.
Overall satisfaction with the genetic counseling appointment is summarized in
Figure 2.2 and demonstrates no statistical significant difference between the two study
groups, with both reporting high overall satisfaction.
2.4.3 Comfort and anxiety level for group genetic counseling sessions
Participants in the group genetic counseling sessions were asked about their
comfort level and anxiety associated with the group portion of their genetic counseling
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using a Likert-scale from 1 (“strongly disagree”) to 5 (“strongly agree”). A summary of
the mean responses to the items is listed in Figure 2.3. A majority of participants reported
that the group genetic counseling sessions reduced anxiety about genetic testing
(M=4.33), allowed them to learn enough to make informed decisions about testing
(M=4.8) and allowed them to learn from others (M=4.8). Additionally, a majority of
respondents denied that group genetic counseling sessions were uncomfortable (M=1.57)
or kept them from asking questions they wanted to ask (M=1.5).
2.4.4 Comfort and anxiety level for individual genetic counseling components
Both study groups were asked about their comfort and anxiety associated with the
individual portion of their genetic counseling experience through Likert-scale measures
(1=strongly disagree; 5=strongly agree) created by the authors. Both study cohorts’
questionnaire shared 4 items; however, the group genetic counseling survey had an
additional item to assess the necessity of the individual genetic counseling component for
group genetic counseling sessions. A summary of the responses to this survey are seen in
Figure 2.4 and demonstrates that overall participants in both the individual and group
genetic counseling study cohorts reported that their anxiety about genetic testing
decreased (p=0.958), they learned enough to make informed decisions about genetic
testing (p=0.272) and they had enough time to ask personal questions in their genetic
counseling experience (p=0.522). Additionally, both study cohorts reported similar low
levels of feeling uncomfortable with their individual genetic counseling experience
(Figure 2.4). A majority of the group genetic counseling cohort reported that the
individual portion of their genetic counseling sessions was necessary after the group

31

genetic counseling portion (M=1.17). There was no significant difference in the
responses between study groups.
The majority of participants receiving only individual genetic counseling (87%,
n=33) reported that they would not be willing to participate in group genetic counseling.
A summary of their response rate can be seen in Figure 2.5.
2.4.5 Qualitative results
The questionnaire for both study groups included free response questions to
gather qualitative data among participants. The individual genetic counseling cohort
questionnaire included two free response items that allowed the participants to elaborate
on their previous responses.
The majority of the individual genetic counseling cohort stated they would not be
willing to have group genetic counseling (n=33; 87%). The most cited explanation for not
wanting to participate in group genetic counseling was concerns for privacy. Respondents
were concerned about sharing personal or family health information in a group and
preferred to have privacy when discussing this information. Other respondents were
concerned that group genetic counseling would not allow them to ask individualized
questions. Of the participants who stated that they would be willing to participate in
group genetic counseling, none responded to the free-response item to elaborate more on
their preferences. Overall comments among the individual genetic counseling cohort
overwhelmingly stated that their appointment was informative and helpful.
The group genetic counseling cohort questionnaire included three free response
items that allowed the participants to elaborate on their responses given in the
quantitative measures. The first free response item probed into the participant’s

32

satisfaction ratings and had a response rate of 36.7% (n=11). A majority of participants
that answered this item described satisfaction with the specific genetic counselor they
saw during their session. Participants cited that the group genetic counseling sessions
were informative and easy to understand. Other comments related to the welcoming
nature of the group and highlighted that individuals in the group asked questions that
helped participants learn more information. One participant stated that she had a difficult
time processing personal information in a group setting by stating “It was hard to process
information so personal in a group of strangers.”
The second free response item explored the participant’s comfort and anxiety
level ratings for their one-on-one time with a genetic counselor. Like the previous
question, many participants referenced their satisfaction with their specific genetic
counselor. All responses were positive and cited that the one-on-one time was
informative, helpful and valuable. A final open-ended question about the overall
appointment found that the session helped with participant stress levels and was a
positive experience.
2.4.6 Time efficiency
A summary of the data can be seen in Figure 2.6 and demonstrates that the
average counselor time spent by the genetic counselor per patient was 35.8 minutes in the
group genetic counseling sessions and 52.4 minutes in the individual genetic counseling
sessions (p=0.0008). For the subset of patients that had their family history taken over the
phone prior to their genetic counseling session (n=21), the average counselor time spent
by the genetic counselor per patient was 32.7 minutes for group genetic counseling and
55 minutes for individual genetic counseling sessions (p=0.003).
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The average times of the group and individual portions for the group genetic
counseling sessions was calculated. For the subset of the group genetic counseling cohort
that had their family history taken during the sessions, the group portion of their sessions
were an average of 23.3 minutes and the individual portion of their session was an
average of 24.2 minutes. For the subset of the group genetic counseling cohort that had
their family history taken before the sessions, the group portion of their sessions was an
average of 24.2 minutes and the individual portion of their session was an average of 18.7
minutes. There was no statistical difference in the group portion time or the individual
time between the two subset cohorts. This data is depicted in Figure 2.7.
2.4.7 Test uptake
For the 68 participants, test uptake was recorded to determine if there was a
difference in genetic testing uptake between study groups. Each of the 68 participants
elected to pursue genetic testing to give a test uptake percentage of 100% in both study
groups.
2.5 Discussion
Advances in genetic testing technology and increased public awareness of HBOC
has led to an increase in cancer genetic counseling referrals (Guo et. al 2017). The current
number of practicing genetic counselors cannot currently meet these demands so
practitioners are trying to increase efficiency within their genetic counseling clinics, in
some cases by implementing new service delivery models (Hoskovec et. al 2018). Before
additional service delivery models can be used clinically, the genetics community needs
to ensure that models result in equivalent levels of patient care. Group genetic counseling
is a service delivery model that been studied to understand its benefits and limitations
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compared to individual genetic counseling. Many group genetic counseling studies in the
literature allow patients to self-select their service delivery model and include a mix of
patients with a variety of indications relating to HBOC, such as personal history of breast
cancer, family history of breast cancer or familial mutations in HBOC genes (Benusiglio
et. al 2017; Calzone et. al 2005; Ridge et. al 2009; Rothwell et al. 2012; Woodson et. al
2015). Our study placed participants into group and individual genetic counseling cohorts
and focused solely on those with a diagnosis of breast cancer meeting national criteria for
evaluation for HBOC. We aimed to determine the utility of group genetic counseling for
this specific group of individuals by assessing patient satisfaction and comfort, efficiency
of the service delivery model, testing uptake and receptiveness to the group model.
Overall, we found that individuals participating in group genetic counseling had similar
reported satisfaction, comfort and anxiety levels compared to those in individual genetic
counseling. Those in group genetic counseling also reported being less overwhelmed by
the information given during their sessions compared to individual genetic counseling
participants. However, we also found that most participants in individual genetic
counseling were not receptive to the idea of group genetic counseling.
2.5.1 Patient satisfaction
It was hypothesized that participants in both cohorts would rate high levels of
satisfaction. In the literature, studies comparing group and individual genetic counseling
cohorts have reported high overall satisfaction in group genetic counseling with no
statistical differences in satisfaction from those receiving individual genetic counseling
(Ridge et. al. 2008; Rothwell et. al. 2011). Our results mirrored past research by showing
that both group and individual genetic counseling cohorts were satisfied with their
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appointments with no statistical differences. This reinforces conclusions made in
previous studies that those participating in group genetic counseling are generally highly
satisfied with their appointments.
Comprehension and psychosocial support are two important aspects of the
traditional individual cancer genetic counseling process and play an important role in the
satisfaction of patients receiving cancer genetic counseling (Riley et al. 2012). In our
study, both cohorts reported high levels of perceived comprehension of the material
covered in their genetic counseling sessions. Other studies have shown that knowledge
gained during group genetic counseling was similar to that of individual genetic
counseling (Ridge et al. 2009; Rothwell et al 2012). While we did not examine
knowledge scores, our data further suggests that group genetic counseling confers the
same perceived levels of comprehension as individual genetic counseling. Patients also
felt heard and understood by their genetic counselor in both cohorts, indicating that group
genetic counseling may provide similar levels of psychosocial support. Both of these
essential genetic counseling elements were not negatively affected by group genetic
counseling, and we believe that high levels of perceived comprehension and support in
our cohorts likely played in role in the high satisfaction ratings between the two groups.
2.5.2 Patient comfort and anxiety
Some studies have found no statistically significant difference in stated comfort
and anxiety for patients involved in group vs. individual genetic counseling, with most
reporting low levels of anxiety and high comfort following both types of sessions
(Rothwell et. al, 2011; Calzone et. al 2005). However, one study reported greater
reduction in anxiety in individual genetic counseling sessions compared to group genetic
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counseling sessions (Cloutier et. al. 2017). It should be noted that this contradicting study
was conducted in a prenatal setting, which may not be comparable to study population in
the cancer setting. The prenatal setting may involve parents or individuals that are
making time sensitive, life-altering decisions which could have an effect on feeling
anxious in a group setting. In our cohort specifically, decisions would not have the same
gravity and did not have the same time sensitivity issues. Our results showed that both the
individual and group genetic counseling cohorts reported high comfort levels and low
anxiety levels post-genetic counseling with no statistically significant differences
between the two cohorts. Our study supports the previous research that found that group
genetic counseling is comfortable and does not increase anxiety for most patients in the
cancer setting.
2.5.3 Group dynamic considerations: benefits
Those in the group genetic counseling cohort were less likely to report being
overwhelmed by the information given during their genetic counseling session. We
hypothesize that this difference can be partially attributed to the benefit of positive group
dynamics. A similar study investigating group genetic counseling for those meeting
genetic testing criteria for HBOC found that group settings offered empowerment to the
patients because they were surrounded by individuals going through similar experiences
(Benusiglio et. al. 2016). Research has also shown that individuals with breast cancer can
benefit from being in support groups that allow interaction with peers going through a
diagnosis (Taleghani et. al 2012). While group genetic counseling does not function as a
support group, individuals may feel a similar sense of community and benefit from
shared experiences. This may consequently lead to feeling less overwhelmed by
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information given in their genetic counseling sessions as they are surround by those
encountering the same circumstances.
Most participants in the group genetic counseling did not report feeling inhibited
in their ability to ask questions. This is consistent with research on group intervention for
breast cancer patients, which shows that patients are comfortable exploring their
experiences and concerns in a group setting (Spiegal et al. 2003). In fact, similar to other
studies, our study found that patients appreciated learning from others when hearing
answers to questions they may have not thought to ask (Benusiglio et. al. 2016).. This
may be a benefit to group genetic counseling over traditional individual genetic
counseling in that it provides the opportunity for the patient to learn more information
through the lens of different patient perspectives and concerns.
2.5.4 Group dynamic considerations: concerns
Some studies have encountered negative group dynamics in group genetic
counseling sessions, such as group conflict, that could have an impact on patients’
experiences with this service delivery model (Ridge et. al 2008; Rothwell et. al. 2011).
These conflicts centered around some individuals meeting criteria for testing and other
group members not, autonomous decision-making about genetic testing uptake and
difficulties accommodating individual needs. We did not experience similar conflicts in
our group genetic counseling sessions, perhaps because of the uniformity in the group
indications and time allocated to an individual genetic counseling sessions after the main
group education sessions.
All patients in our group genetic counseling sessions were new diagnoses of
breast cancer and all met criteria for genetic testing. Perhaps because of this, we did not
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encounter group conflict involving some participants meeting criteria and some not. In
studies of group therapy, it has been shown that conflict is reduced in groups composed
of individuals with similar circumstance due to cohesiveness and built trust which may
also translate to the genetic counseling clinic as well (Ridge et. al. 2008).
Finally, most of our group genetic counseling cohort reported that the individual
genetic counseling time was necessary after the group session and allowed them enough
time to ask their personal questions. It is possible that the opportunity for conflict due to
individual concerns that has been reported in past studies was reduced because patients
knew they would have time to address their personal concerns during the individual
session. This follow up individual time appears to be necessary and beneficial to patient
satisfaction. These findings may point to helpful factors to consider when designing a
group genetic counseling SDM.
2.5.5 Efficiency of group genetic counseling
This study was also focused on determining if group genetic counseling increases
efficiency in the cancer genetic counseling clinic. We hypothesized that incorporating
group genetic counseling into our care would help to reduce genetic counselor time per
patient. We found that genetic counselor time per patient in the group genetic counseling
cohort was significantly less. This could increase efficiency in our clinic because genetic
counselors could see more patients in the same amount of time they would typically only
see one patient. Our results mirror findings in previous studies examining efficiency of
group genetic counseling in the cancer setting (Calzone et al 2005; Cloutier et. al 2017;
Ridge et. al 2008).
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During a portion of our data collection, we had genetic counseling assistants that
took family history on the phone before group and individual genetic counseling sessions.
Not surprisingly, this saved time. The decrease in overall genetic counselor time per
patient seen in the group genetic counseling cohort when family history was taken prior
to the session was less than expected, but overall there was a time savings benefit of
taking family history prior to genetic counseling sessions. Even though it was not
statistically significant, perhaps due to low numbers in each group, it still highlights a
benefit of having a genetic counseling assistants in clinics to provide increased efficiency
advantages with the group genetic counseling service delivery model (Pirzadeh-Miller et
al. 2016). Use of genetic counseling assistants and technologies such as electronic
pedigree collection via on-line HIPPA-compliant portals should be further studied to
determine their impact on efficiency and patient satisfaction.
Previous research studies reported difficulties in coordination of group genetic
counseling due to issues with the logistics of scheduling group sessions (Calzone et. al.
2005; Ridge et. al 2008). In our program, we only had one available date and time for
group genetic counseling sessions. While this did not result in coordination problems
during our study, this may be a limitation to filling up group genetic counseling sessions
in clinics where there is only one available day and time for group genetic counseling.
Adding multiple group sessions per week would give more options to patients when
scheduling.
A study of group genetic counseling for HBOC hypothesized that logistical issues
for scheduling group appointments would increase with attempts to homogenize group
participants (Ridge et. al 2008). Stratifying our group genetic counseling cohort to
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include just those with a new diagnosis of breast cancer meant there were less patients
available to fill the group sessions which could affect the efficiency benefits of group
genetic counseling overall. Although scheduling a larger group would maximize the
impact of time savings, we believe the benefits in homogenizing the group to provide
more specific education and promote positive group dynamics, outweigh the downside of
having a smaller average group size.
2.5.6 Patient receptiveness to group genetic counseling
Studies in the literature have shown that, when given the choice, patients
receiving cancer genetic counseling prefer to have individual genetic counseling over
group genetic counseling (Ridge et al 2008; Rothwell et. al 2011). In this study, we also
found overwhelmingly that given a choice, most would not have been willing to have a
group genetic counseling session. Similar to main themes cited in other studies, most of
our participants cited privacy concerns and worries about discussing personal information
in a group setting as their main reasons for not being receptive to group genetic
counseling (Ridge et al 2008). However, as discussed earlier, those participating in group
genetic counseling via random assignment reported similar satisfaction and comfort
levels as those in individual genetic counseling. During our data collection, no
individuals assigned to group genetic counseling declined during the scheduling process
once they were informed of the nature of the appointment. Individuals scheduling the
genetic counseling appointments offered a brief explanation of the group genetic
counseling process to patients during the scheduling process. They explained that the
group portion of their session would be mainly education and that they would also have
individual time with a genetic counselor to address specific concerns and testing
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decisions. This may have helped ease the worries of those hesitant about group genetic
counseling and served to set expectations. Also, since group genetic counseling was the
only option offered, individuals may have not thought about it or had any worries going
into their session. It appears that when group genetic counseling is presented as the norm
and explained while scheduling the appointment, patients are receptive to this service
delivery model. This is reinforced by a study that asked participants their preferred
service delivery model post-genetic counseling and found that most participants preferred
the model they were randomly assigned (Calzone et. al 2005). The idea of random
assignment or presenting group counseling as the norm is important to consider when
designing a group genetic counseling SDM.
It should be noted that in the group genetic counseling cohort, we did have one
patient who reported being uncomfortable with their group genetic counseling session;
however, she did not state specific reasons why. It is no surprise that this service delivery
model may not be best suited to every individual, as with any service delivery model; but,
our data shows that a majority of patients had positive experiences with group genetic
counseling.
2.5.7 Testing uptake in group genetic counseling
A study looking at group genetic counseling for HBOC have reported differences in test
uptake between group and individual genetic counseling and cite concerns about group
influence on decision making (Rothwell et al 2011). The Rothwell et al study investigated
individuals with a personal and/or family history that met NCCN testing guidelines and
indicated an a priori risk of a BRCA1/2 mutation above 25%. Furthermore, their group
genetic counseling cohort had more unaffected individuals (35.7%) then their individual
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genetic counseling cohort (16.1%). Both of these factors could explain the difference in
test uptake. Unaffected individuals may have other factors that weigh into their decision
to pursue testing that those affected do not experience, such as not being the best person
to test in a family or concerns about life insurance. In our study, we found no difference
in testing uptake between the two study cohorts. Since all of our patients were affected
with cancer, they may have been more motivated to pursue testing for treatment
decisions. It can be argued that, with this indication especially, many patients come into
sessions with plans to undergo genetic testing. Also, our patients also were not asked to
discuss their testing choices in the group setting, and they reflected positively on the
individual meetings following group genetic counseling sessions. Obviously, eliminating
group influence cannot be guaranteed with this model, but individual time with a genetic
counselor can help patients to explore their views separate of the group to come to an
autonomous decision.
2.6 Limitations and future research
2.6.1 Limitations
Our study population was primarily composed of highly educated Caucasian
women with a new diagnosis of breast cancer. Due to this uniformity in participant
demographics, our findings may not stratify to other populations. Different sexes, races
and education levels may have different comfort levels, satisfaction and receptiveness to
group genetic counseling, especially when seen together in a group. Also, our sample size
was relatively small. Differences in time efficiency and patient perspectives may be
better seen in a larger sample. We also assessed patient perceptions of their genetic
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counseling session immediately after, while they were still in our clinic. This may not
accurately depict patient perspectives in the long term.
Our cohorts were exclusively made up of those with a personal, recent diagnosis
of breast cancer. With this homogenous group, we cannot predict that these results would
be seen in a study cohort with mixed indications for cancer genetic counseling.
Individuals with different indications may have different responses. For example,
unaffected populations may need more time for discussions on decision making then
those in an affected population who meet criteria.
Some of the time efficiency data was derived from a subset of individuals that
had their family history taken over the phone prior to genetic counseling sessions by
genetic counseling assistants. We did try to account for this and still found that group
genetic counseling is more time efficient than individual genetic counseling, even when
family history is taken during the session. However, we realize that some of the data
given in our results is not applicable to clinics who do not have access to genetic
counseling assistants or electronic pedigree collection prior to genetic counseling
sessions.
Finally, our group sizes were relatively small. Although groups could be as large
at 4, they were not all filled. This was mainly due to the number of patients with a new
diagnosis of breast cancer referred, which varied by week. Another limiting factor was
patients’ availability since group genetic counseling was only held on one day and time a
week. This could have impacted the efficiency of this service delivery model. However,
as the number of individuals increases in a group genetic counseling session, the time
savings would presumably only become more significant.
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2.6.2 Future research
We found benefits to homogenizing our group genetic counseling cohort.
However, completing a similar study on patients with different indications would assess
if group genetic counseling is beneficial for other types of patients beyond those with a
new diagnosis of breast cancer. Additionally, we realize that satisfaction and comfort
level are not the only defining characteristics of an effective service delivery model.
Further research needs to be conducted to understand the effects of group genetic
counseling on other factors such as depression levels, cancer worry, and knowledge. It
may also be beneficial to study patient perceptions at different time intervals following
genetic counseling sessions to assess the long-term impact of group genetic counseling.
Additionally, while we found that group genetic counseling offers increased efficiency in
the cancer clinic, we could not say with certainty that this affects direct access to cancer
genetic counseling services. Finally, groups in underserved and less educated
communities should be evaluated to see if these results are true among a more diverse
population. This study did not directly measure the impact of group genetic counseling on
the overall number of patients that could be accommodated by a single genetic counselor,
although we infer that more patients could be seen based on the time savings
demonstrated. More specific studies need to be done to assess how this service delivery
model can impact access to cancer genetic counseling overall.
2.7 Conclusion
As cancer genetic counseling referrals increase, the current landscape of genetic
counseling service delivery is shifting towards incorporating additional models of care
into the clinic to accommodate demands. Group genetic counseling provides an effective
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way to increase efficiency while maintaining similar patient satisfaction and comfort
levels experienced in individual genetic counseling. Group genetic counseling may also
have the added benefit of making the large amount of information covered in a genetic
counseling session less overwhelming. However, the individual time following group
genetic counseling also appears to be important to allow for discussion about patients’
specific history and concerns while promoting autonomous decision making. In addition
to the individual time, this study highlighted the potential benefits of homogenizing
group indications or circumstances when designing a group genetic counseling service
delivery model. It also demonstrates the benefits of presenting group genetic counseling
as the norm and not offering different service delivery model options to patients. Even
though most patients are satisfied and are comfortable in a group setting, when given the
choice, patients are unlikely to choose group genetic counseling. While more research
needs to be done to assess a more diverse population and benefits to other patient groups,
we believe group genetic counseling is a promising service delivery model that can be
beneficial for patients and providers in the cancer genetic counseling clinic.
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Table 2.1 Demographic characteristics of study participants
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Characteristics
Age (n= 65)
20-30
31--40
41-50
51-60
61-70
71-80
Race (n=68)
Caucasian
African American
Asian
Multiracial
Did not respond
Ethnicity (n=68)
Hispanic
Non-Hispanic
Did not respond
Education (n=68)
Some High School
High School or GED
Some College
Associates/Technical Degree
Bachelor's Degree

Individual (%)

Group (%)

Total (%)

2.6
15.8
21.1
23.7
10.5
23.7

3.3
3.3
40.0
20.0
23.3
3.3

3.1
10.8
30.8
23.1
16.9
15.4

p-value
0.375

0.300
55.3
34.2
0.0
2.6
7.9

66.7
30.0
3.3
0.0
0.0

60.3
32.4
1.5
1.5
4.4
0.913

2.6
84.2
13.2

3.3
86.7
10.0

2.9
85.3
11.8
0.986

2.7
13.5
24.3
5.4
29.7

3.3
10.0
20.0
6.7
30.0

2.9
11.8
22.1
5.9
29.4
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Postgraduate Degree
Did not respond
Income (n=68)
Less than 25K
25K-50K
50K-75K
75K-100K
100K-125K
More than 125K
Did not respond
Health Insurance (n=68)
Private or Employer Based
Medicaid
Medicare
Tricare
Other
Did not respond
Relationship Status (n=68)
Single, Never Married
Single, Living with Significant
Other
Married
Widowed
Divorced
Separated
Did not respond

21.6
2.7

23.3
6.7

22.1
5.9
0.443

10.5
26.3
7.9
18.4
0.0
10.5
26.3

6.7
23.3
20.0
10.0
6.7
6.7
26.7

8.8
25.0
13.2
14.7
2.9
8.8
26.5
0.228

50.0
7.9
7.9
10.5
7.9
15.8

76.7
3.3
10.0
3.3
3.3
3.3

61.8
5.9
8.8
7.4
5.9
10.3
0.121

15.8

3.3

10.3

2.6
50.0
7.9
21.1
0.0
2.6

0.0
76.7
3.3
6.7
3.3
6.7

1.5
61.8
5.9
14.7
1.5
4.4
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Family History of Cancer (n=68)
Yes
No
Did not respond
Support individual present at
appointment (n=68)
Yes
No
Support individuals (n=28)
Friend
Child
Significant Other
Sibling
Parent

0.527
84.2
10.5
5.3

76.7
20.0
3.3

80.9
14.7
4.4
0.861

42.1
57.9

40.0
60.0

41.2
58.8
0.342

0.0
12.5
37.5
12.5
37.5

8.3
16.7
58.3
8.3
8.3

3.6
14.3
46.4
10.7
25

Cancer Genetic Counseling Satisfaction Measure
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50

Survey Items

I FELT THAT THE INFORMATION WAS
OVERWHELMING

P-Values

1.77

p = 0.10

2.74

I FEEL LIKE I UNDERSTOOD THE INFORMATION
PRESENTED DURING MY APPOINTMENT

4.93
4.84

p = 0.253

THE GC APPOINTMENT WAS VALUABLE TO ME

4.93
4.89

p = 0.640

4.86
4.86

p = 0.979

4.97
4.79

p = 0.057

MY GC WAS TRULY CONCERNED ABOUT MY
WELL-BEING
THE GC APPOINTMENT WAS THE RIGHT LENGTH
OF TIME I NEEDED
I FEEL BETTER ABOUT MY HEALTH AFTER
MEEEING WITH MY GC

4.57
4.47

MY GC HELPED ME TO IDENTIFY WHAT I
NEEDED TO KOW TO MAKE DECISIONS ABOUT…
MY GC SEEMED TO UNDERSTAND THE STRESSES
I WAS FACING

Group Session Participants' Rating
Individual Session Participants' Rating

1

2

3

Average Rating

4

p = 0.630

4.9
4.87

p = 0.728

4.9
4.82

p = 0.388

5

1 = Strongly Disagree
5 = Strongly Agree

Figure 2.1 Satisfaction and distress between individual and group genetic counseling participants

Overall Satisfaction
5

Satisfaction Rating

4.5

4.95

4.83

4
3.5
3
2.5
2
1.5
1

Individual Session Participants' Group Session Participants'
Rating
Rating
1 = Least satisfied
Study Group
p-value = 0.360
5 = Most satisfied

Figure 2.2 Overall satisfaction between individual and group genetic counseling
participants
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"Participating in a group genetic counseling session..."

Survey Items

REDUCED MY ANXIETY ABOUT GENETIC TESTING

4.33

ALLOWED ME TO LEARN ENOUGH TO MAKE AN INFORMED
DECISION ABOUT GENETIC TESTING

4.8

WAS UNCOMFORTABLE

1.57
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KEPT ME FROM ASKING A QUESTION I WANTED TO ASK

1.5

ALLOWED ME TO LEARN FROM OTHERS
0 = Strongly Disagree
5 = Strongly Agree

4.8
0

1

2

3

4

Average Rating

Figure 2.3 Group genetic counseling study group comfort and anxiety ratings for the group portion of their genetic counseling
appointment

5

Individual Session Participants'
Rating
Group Session Participants'
Rating

"The one-on-one time I spent with my genetic counselor..."
WAS UNNECESSARY AFTER THE GROUP
GENETIC COUNSELING SESSION

1.17

4.42

53

Survey Items

REDUCED MY ANXIETY ABOUT GENETIC
TESTING

p-value = 0.958

4.43

ALLOWED ME TO LEARN ENOUGH TO
MAKE AN INFORMED DECISION ABOUT
GENETIC TESTING

4.79

p-value = 0.272

4.9

p-value = 0.266

1.61
WAS UNCOMFORTABLE
1.27

4.95

WAS ENOUGH TIME FOR ME TO ASK MY
PERSONAL QUESTIONS

p-value = 0.522

4.87
0

1

2

3

4

5

1 = Strongly Disagree
5= Strongly Agree

Average Rating

Figure 2.4 Comfort and anxiety ratings for the individual components of both study cohorts’ genetic counseling experience

13%
n=5

No
Yes

87%
n = 33
Figure 2.5 Individual genetic counseling participant theoretical willingness to receive
group genetic counseling

p-value = 0.0008
52.4

35.8

GROUP GENETIC COUNSELING

INDIVIDUAL GENETIC COUNSELING

Figure 2.6 Average counselor time per patient (minutes) based on service delivery model
for those with family history taken during their genetic counseling session
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Average time (minutes) of the individual and group
portions for the group genetic counseling cohort
Group portion

Individual portion

24.2

18.7

23.3

24.2

FAMILY HISTORY TAKEN DURING SESSION

FAMILY HISTORY TAKEN BEFORE SESSION

Figure 2.7 Average time (minutes) of the individual and group portions for the group
genetic counseling cohort
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APPENDIX A – STUDY RECRUITMENT LETTER
The following letter was distributed to patients involved in both group and individual
genetic counseling sessions at the USC Specialty Cancer Clinic.
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Hello,
You are being invited to participate in this research study because you have had cancer
genetic counseling due to a personal diagnosis of cancer. The goal of this study is to
evaluate your satisfaction with your genetic counseling appointment. The title of this
study is, “Impact of service delivery model on access and patient perceptions of genetic
counseling for hereditary breast and ovarian cancer (HBOC).” It has been approved by
the University of South Carolina IRB.
Your participation in this study is completely voluntary. This study involves answering
some questions about your satisfaction with your genetic counseling appointment. All
responses are anonymous, will be kept confidential and will not be a part of your medical
record. You may stop your participation at any time or choose not to answer every
questions. If you choose to complete the questionnaire, your name can be entered into a
raffle to win a gift cards to Amazon. If you wish to be entered into the raffle, please leave
your e-mail address or phone number at the bottom of this page. It will not be connected
to your answers to these questions. Your time is greatly appreciated and we hope these
results will help us to better serve future patients.
Anything that we learn from this study and present to others will not have any identifying
information. If you have any questions, please do not hesitate to contact me by email at
alyssa.gates@uscmed.sc.edu or phone at (219)-707-6578.
Sincerely,
Alyssa Gates
Genetic Counseling Student
University of South Carolina – Columbia

Name: __________________________________
Email: ___________________________
Phone Number: _____________________________
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APPENDIX B – GROUP GENETIC COUNSELING QUESTIONNAIRE
The following questionnaire was distributed to participants receiving group genetic
counseling at the USC Specialty Cancer Clinic.
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1. Please circle the response that best fits your present feelings about your overall
appointment (including both the group and individual portions of your
appointment).
Strongly
disagree
My genetic
counselor seemed
to understand the
stresses I was
facing.
My genetic
counselor helped
me to identify what
I needed to know to
make decisions
about what would
happen.
I feel better about
my health after
meeting with my
genetic counselor.
The genetic
counseling
appointment was
the right length of
time I needed.
My genetic
counselor was truly
concerned about my
well-being.
The genetic
counseling
appointment was
valuable to me.
I feel like I
understood the
information
presented during
my appointment.
I felt that the
information was
overwhelming.

Disagree
somewhat

Uncertain

Agree
somewhat

Agree
strongly

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

64

2. Please rank your overall satisfaction with your genetic counseling appointment
today. (circle one).
1

2

3

4

5

3. Please circle the response that best fits your present feelings about your group
genetic counseling appointment.

Participating in a group genetic counseling session…

Allowed me to
learn from others

Kept me from
asking a question I
wanted to ask
Was
uncomfortable
Allowed me to
learn enough to
make an informed
decision about
genetic testing
Reduced my
anxiety about
genetic testing

Strongly
disagree

Disagree
somewhat

Uncertain

Agree
somewhat

Agree
strongly

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Please explain or elaborate on any of your ratings for the group counseling session
above:
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
__________________
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4. Please circle the response that best fits your present feelings about your one-onone time spent with a genetic counselor.

The one-on-one time I spent with my genetic counselor…

Was enough time
for me to ask my
personal questions
Was unnecessary
after the group
genetic counseling
session
Was
uncomfortable
Allowed me to
learn enough to
make an informed
decision about
genetic testing
Reduced my
anxiety about
genetic testing

Strongly
disagree

Disagree
somewhat

Uncertain

Agree
somewhat

Agree
strongly

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Please explain or elaborate on any of your ratings for your one-on-one time:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
__________________

Please leave any additional thoughts/comments/feelings you had about your appointment
below:
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________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________

Demographics:
Age: I am _______ years old.

What is your race?:
Please check one.
White
African American/Black
American Indian/Alaskan Native
Asian
Native Hawaiian/Other Pacific Islander
Two or more races
Prefer not to answer
Other: _____________
What is your ethnicity?
Please check one.
Non-Hispanic
Hispanic
Prefer not to answer
Education:
Please check the highest level of education you have received.
Some high school
High school degree/GED
Some college
Associate degree/Technical degree or certificate
Bachelor degree
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Post-graduate degree (MD, Ph.D., MS, JD)
Health Insurance:
Please check one.
Private/Employer-based insurance
Medicaid
Medicare
TRICARE
I do not currently have health insurance
Other

Income:
Please check your current level of income.
<$25,000
$25,000-$50,000
$50,000-$75,000
$75,000-$100,000
$100,000-$125,000
>$125,000
Prefer not to answer
Current Relationship Status:
Please check one.
Single, never married
Single, but living with significant other
Married
Widowed
Divorced
Separated
Domestic Partnership or civil union
Do you have a family history of cancer?
Please check one.
Yes
No
Did you bring anyone with you to your appointment?
Please check one.
Yes

If yes, whom? ______________
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No
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APPENDIX C – INDIVIDUAL GENETIC COUNSELING QUESTIONNAIRE
The following questionnaire was distributed to participants receiving group genetic
counseling at the USC Specialty Cancer Clinic.
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1. Please circle the response that best fits your present feelings.
Strongly
disagree
My genetic
counselor seemed
to understand the
stresses I was
facing.
My genetic
counselor helped
me to identify what
I needed to know to
make decisions
about what would
happen.
I feel better about
my health after
meeting with my
genetic counselor.
The genetic
counseling session
was the right length
of time I needed.
My genetic
counselor was truly
concerned about
my well-being.
The genetic
counseling session
was valuable to me.
I feel like I
understood the
information
presented during
my session
I felt that the
information was
overwhelming

1

1

Disagree
somewhat
2

Uncertain

3

2

Agree
somewhat
4

3

4

Agree
strongly
5

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

2. Please rank your overall satisfaction with your genetic counseling appointment
today. (circle one).
1

2

3
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4

5

3. You received individual genetic counseling today. Do you think you would have
been comfortable with receiving this information in a group setting with other
patients? (circle one)

Yes

No

Please explain below:
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
_____________________________

4.

Please circle the response that best fits your present feelings about your genetic
counseling appointment

The genetic counseling session I had today…

Was enough time
for me to ask my
personal questions
Was
uncomfortable
Allowed me to
learn enough to
make an informed
decision about
genetic testing

Strongly
disagree

Disagree
somewhat

Uncertain

Agree
somewhat

Agree
strongly

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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Reduced my
anxiety about
genetic testing

1

2

3

4

5

Please leave any thoughts/comments/feelings you had about your appointment below:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
___________________________________

Demographics:
Age: I am _______ years old.

What is your race?:
Please check one.
White
African American/Black
American Indian/Alaskan Native
Asian
Native Hawaiian/Other Pacific Islander
Two or more races
Prefer not to answer
Other: _____________
What is your ethnicity?
Please check one.
Non-Hispanic
Hispanic
Prefer not to answer
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Education:
Please check the highest level of education you have received.
Some high school
High school degree/GED
Some college
Associate degree/Technical degree or certificate
Bachelor degree
Post-graduate degree (MD, Ph.D., MS, JD)

Health Insurance:
Please check one.
Private/Employer-based insurance
Medicaid
Medicare
TRICARE
I do not currently have health insurance
Other

Income:
Please check your current level of income.
<$25,000
$25,000-$50,000
$50,000-$75,000
$75,000-$100,000
$100,000-$125,000
>$125,000
Prefer not to answer
Current Relationship Status:
Please check one.
Single, never married
Single, but living with significant other
Married
Widowed
Divorced
Separated
Domestic Partnership or civil union
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Do you have a family history of cancer?
Please check one.
Yes
No
Did you bring anyone with you to your appointment?
Please check one.
Yes
No

If yes, whom? ______________
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